- Home
- EBMT vs ELDN Comparison
EBMT vs ELDN Comparison
Compare EBMT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBMT
- ELDN
- Stock Information
- Founded
- EBMT 1922
- ELDN 2004
- Country
- EBMT United States
- ELDN United States
- Employees
- EBMT N/A
- ELDN N/A
- Industry
- EBMT Major Banks
- ELDN Biotechnology: Pharmaceutical Preparations
- Sector
- EBMT Finance
- ELDN Health Care
- Exchange
- EBMT Nasdaq
- ELDN Nasdaq
- Market Cap
- EBMT 130.6M
- ELDN 140.3M
- IPO Year
- EBMT N/A
- ELDN N/A
- Fundamental
- Price
- EBMT $16.60
- ELDN $4.00
- Analyst Decision
- EBMT
- ELDN Strong Buy
- Analyst Count
- EBMT 0
- ELDN 1
- Target Price
- EBMT N/A
- ELDN $16.00
- AVG Volume (30 Days)
- EBMT 20.6K
- ELDN 985.1K
- Earning Date
- EBMT 10-29-2024
- ELDN 11-12-2024
- Dividend Yield
- EBMT 3.45%
- ELDN N/A
- EPS Growth
- EBMT N/A
- ELDN N/A
- EPS
- EBMT 1.09
- ELDN N/A
- Revenue
- EBMT $80,038,000.00
- ELDN N/A
- Revenue This Year
- EBMT N/A
- ELDN N/A
- Revenue Next Year
- EBMT $8.40
- ELDN N/A
- P/E Ratio
- EBMT $15.27
- ELDN N/A
- Revenue Growth
- EBMT N/A
- ELDN N/A
- 52 Week Low
- EBMT $11.63
- ELDN $1.11
- 52 Week High
- EBMT $17.65
- ELDN $5.54
- Technical
- Relative Strength Index (RSI)
- EBMT 51.64
- ELDN 49.97
- Support Level
- EBMT $16.03
- ELDN $4.74
- Resistance Level
- EBMT $17.14
- ELDN $5.40
- Average True Range (ATR)
- EBMT 0.26
- ELDN 0.53
- MACD
- EBMT -0.03
- ELDN -0.11
- Stochastic Oscillator
- EBMT 51.35
- ELDN 24.51
About EBMT Eagle Bancorp Montana Inc.
Eagle Bancorp Montana Inc operates as a bank holding company. It provides loan and deposit services. The company focuses on residential loans, commercial real estate loans, commercial loans, consumer loans, and home equity loan products. The bank also offers deposit accounts which include checking, savings, money market, individual retirement accounts, and certificates of deposit accounts. It is a diversified lender with a focus on residential mortgage loans, commercial real estate mortgage loans, commercial business loans, agricultural loans, and second mortgage/home equity loan products.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.